Evidence map›Paper›PMID 34983564›Full record

ArticleJournal of nanobiotechnology2022

Mn doped Prussian blue nanoparticles for T

Quan Tao, Genghan He, Sheng Ye, Di Zhang, Zhide Zhang, Li Qi, Ruiyuan Liu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nanobiotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. CsInternational journal of nanomedicine · 2024
    Article
  7. Cancer diagnosis and treatment platform based on manganese-based nanomaterials.Frontiers in bioengineering and biotechnology · 2024
    Review
  8. Review
  9. [Manganese-based nanoparticles for chemodynamic therapy of gastrointestinal cancer].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Quan Tao *Guangdong Provincial Key Laboratory of Medical Image Processing, School of Biomedical Engineering, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Genghan He *Guangdong Provincial Key Laboratory of Medical Image Processing, School of Biomedical Engineering, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Sheng YeGuangdong Provincial Key Laboratory of Medical Image Processing, School of Biomedical Engineering, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Di ZhangGuangdong Provincial Key Laboratory of Medical Image Processing, School of Biomedical Engineering, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Zhide ZhangGuangdong Provincial Key Laboratory of Medical Image Processing, School of Biomedical Engineering, Southern Medical University, Guangzhou, 510515, Guangdong, China. zider@smu.edu.cn.
Li QiGuangdong Provincial Key Laboratory of Medical Image Processing, School of Biomedical Engineering, Southern Medical University, Guangzhou, 510515, Guangdong, China. qili@smu.edu.cn.
Ruiyuan LiuGuangdong Provincial Key Laboratory of Medical Image Processing, School of Biomedical Engineering, Southern Medical University, Guangzhou, 510515, Guangdong, China. ruiyliu@smu.edu.cn.

Funding

National Natural Science Foundation of China 81671749
6 · The paper itself

Abstract

backgroundCombining the multimodal imaging and synergistic treatment in one platform can enhance the therapeutic efficacy and diagnosis accuracy.

resultsIn this contribution, innovative Mn-doped Prussian blue nanoparticles (MnPB NPs) were prepared via microemulsion method. MnPB NPs demonstrated excellent T

conclusionsOverall, this Mn doped Prussian blue nanoplatform with multimodal imaging and chemodynamic/mild temperature photothermal co-therapy provides a reliable tool for tumor treatment.

Indexed as

AnimalsCell Line, TumorFemaleFerrocyanidesHumansMagnetic Resonance ImagingManganeseMetal NanoparticlesMiceMice, NudePhotoacoustic TechniquesPhotochemotherapyPhotothermal TherapyTheranostic Nanomedicineferric ferrocyanideFerrocyanidesManganeseChemodynamic therapyFenton reactionMild temperature photothermal therapyMR imagingPhotoacoustic imaging

Identifiers

PMID34983564
PMCPMC8725273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.